Skip to main content
. Author manuscript; available in PMC: 2023 Mar 1.
Published in final edited form as: Optom Vis Sci. 2022 Mar 1;99(3):213–227. doi: 10.1097/OPX.0000000000001867

Appendix Table A8.

Distribution of Parent-reported Frequency of the Child’s Diplopia and Change in Diplopia Frequency from Baseline By Treatment Group.

Baseline 4 weeks 8 weeks

Parent-reporteda Binocular
Treatment
Continued
Spectacles
Binocular
Treatment
Continued
Spectacles
Binocular
Treatment
Continued
Spectacles

N % N % N % N % N % N %

Per Group(N) 91 90 87 84 86 84

Diplopia frequency b
 Never 87 96% 86 96% 78 90% 79 94% 78 91% 78 93%
 Less than once a week 2 2% 0 0% 2 2% 2 2% 4 5% 4 5%
 Once a week 0 0% 3 3% 4 5% 0 0% 1 1% 1 1%
 Once a day 1 1% 1 1% 3 3% 3 4% 2 2% 0 0%
 Up to 10 times a day 1 1% 0 0% 0 0% 0 0% 1 1% 0 0%
 More than 10 times a day 0 0% 0 0% 0 0% 0 0% 0 0% 0 0%
 All the time 0 0% 0 0% 0 0% 0 0% 0 0% 1 1%

Change in diplopia frequency from baseline c
 Increased frequency (> 2 levels) 6 7% 2 2% 2 2% 1 1%
 Similar frequency (within 1 level) 79 92% 80 95% 82 96% 80 95%
 Reduced frequency (> 2 levels) 1 1% 2 2% 1 1% 3 4%
a

The parental assessment may be missing if the parent/guardian was not available at the visit.

b

The exact Wilcoxon rank sum test was used to compare diplopia frequency at 4 weeks (P > .99) and at 8 weeks (P = .50) between the treatment groups.

c

The exact Wilcoxon rank sum test was used to compare the change in diplopia frequency from baseline to 4 weeks (P = .49) and to 8 weeks (P = .25) between the treatment groups.